These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1071390)

  • 1. Effects of acute and chronic inhalation of hashish, marijuana, and delta 9-tetrahydrocannabinol on brain electrical activity in man: evidence for tissue tolerance.
    Fink M
    Ann N Y Acad Sci; 1976; 282():387-98. PubMed ID: 1071390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana consumption and tolerance to physiological and subjective effects.
    Babor TF; Mendelson JH; Greenberg I; Kuehnle JC
    Arch Gen Psychiatry; 1975 Dec; 32(12):1548-52. PubMed ID: 1200773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.
    Pijlman FT; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    Addict Biol; 2005 Jun; 10(2):171-80. PubMed ID: 16191670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication.
    Theunissen EL; Kauert GF; Toennes SW; Moeller MR; Sambeth A; Blanchard MM; Ramaekers JG
    Psychopharmacology (Berl); 2012 Mar; 220(2):341-50. PubMed ID: 21975580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cannabinoids on serum cortisol and prolactin in humans.
    Ranganathan M; Braley G; Pittman B; Cooper T; Perry E; Krystal J; D'Souza DC
    Psychopharmacology (Berl); 2009 May; 203(4):737-44. PubMed ID: 19083209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological aspects of cannabis use.
    Stefanis C
    NIDA Res Monogr; 1978; (19):149-78. PubMed ID: 34102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of cannabis on cognitive, perceptual, and motor performance in chronic hashish users.
    Dornbush RL; Kokkevi A
    Ann N Y Acad Sci; 1976; 282():313-22. PubMed ID: 1071385
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol, EEG and behavior:the importance of adaptation to the testing milieu.
    Constoe PF; Jones BC; Chin L
    Pharmacol Biochem Behav; 1975; 3(2):173-7. PubMed ID: 1144477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
    Kawasaki H; Watanabe S; Ueki S
    Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging studies in cannabis users.
    Chang L; Chronicle EP
    Neuroscientist; 2007 Oct; 13(5):422-32. PubMed ID: 17901252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of cannabis tolerance and dependence.
    Jones RT; Benowitz NL; Herning RI
    J Clin Pharmacol; 1981; 21(S1):143S-152S. PubMed ID: 6271820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to marijuana: heart rate and subjective "high".
    Nowlan R; Cohen S
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):550-6. PubMed ID: 913022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.